TP53 and lung carcinoma: Based on our studies, the presence or absence of EphA5 dictates the terminal fate of IR-exposed lung cancer cells: in the absence of EphA5, p53-proficient cells become senescent, and in the absence of both EphA5 and p53, lung cancer cells die.